MDMA Impairs Response to Water Intake in Healthy Volunteers
Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE
Advances in pharmacological sciences · 4 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (clasificado por nuestro filtro de IA)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Institutes of Health
- Universidad u hospital
- University of California, San Francisco
- Gobierno
- National Institute on Drug Abuse
- Gobierno
- National Center for Research Resources
- Gobierno
- NIDA NIH HHS
- Gobierno
- NCRR NIH HHS
- Subvenciones
- National Center for Research Resources (DA016776); National Institute on Drug Abuse (R01 DA016776); National Center for Research Resources (DA017716); National Center for Research Resources (UCSF-CTSI UL1 RR-024131); National Center for Research Resources (UL1 RR024131); University of California, San Francisco (UL1RR024131); National Institute on Drug Abuse (R01 DA017716); National Institutes of Health (UL1-RR-024131); National Institutes of Health (RR024131); National Institutes of Health (DA016776); National Institutes of Health (DA017716); National Institutes of Health (DA017716 and DA016776); National Institutes of Health (UCSF- CTSI UL1 RR024131)
Según 6 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2016-01-01 · Adv Pharmacol Sci · vol. 2016 · págs. 1–11
- Editorial
- Hindawi Publishing Corporation
- Citado
- 13 citas · más que el 74% de estudios similares · 1.2× el promedio de su campo
- Referencias
- 66 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Forensic Toxicology and Drug Analysis · Psychedelics and Drug Studies · Neurotransmitter Receptor Influence on Behavior
- Palabras clave
- MDMA, Placebo, Medicine, Hyponatremia, Antidiuretic, Prazosin, Pharmacology, Anesthesia, Internal medicine, Endocrinology, Hormone, Antagonist
7 autores
- Matthew J. Baggott🇺🇸 · autor de correspondenciaFriends Research Institute
- Kathleen J. Garrison🇺🇸Friends Research Institute
- Jeremy Coyle🇺🇸University of California, Berkeley
- Gantt P. Galloway🇺🇸Friends Research Institute
- Allan J. Barnes🇺🇸National Institute on Drug Abuse
- Marilyn Ann Huestis🇺🇸National Institute on Drug Abuse
- John E. Mendelson🇺🇸Friends Research Institute
Resumen
El texto original del estudio, en el idioma en que se publicó.
Hyponatremia is a serious complication of 3,4-methylenedioxymethamphetamine (MDMA) use. We investigated potential mechanisms in two double-blind, placebo-controlled studies. In Study 1, healthy drug-experienced volunteers received MDMA or placebo alone and in combination with the alpha-1 adrenergic inverse agonist prazosin, used as a positive control to release antidiuretic hormone (ADH). In Study 2, volunteers received MDMA or placebo followed by standardized water intake. MDMA lowered serum sodium but did not increase ADH or copeptin, although the control prazosin did increase ADH. Water loading reduced serum sodium more after MDMA than after placebo. There was a trend for women to have lower baseline serum sodium than men, but there were no significant interactions with drug condition. Combining studies, MDMA potentiated the ability of water to lower serum sodium. Thus, hyponatremia appears to be a significant risk when hypotonic fluids are consumed during MDMA use. Clinical trials and events where MDMA use is common should anticipate and mitigate this risk.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.